Previous close | 133.80 |
Open | 136.08 |
Bid | 110.00 x 800 |
Ask | 180.44 x 1400 |
Day's range | 131.69 - 137.80 |
52-week range | 126.94 - 231.00 |
Volume | |
Avg. volume | 305,441 |
Market cap | 4.811B |
Beta (5Y monthly) | 1.48 |
PE ratio (TTM) | 27.72 |
EPS (TTM) | 4.83 |
Earnings date | 25 Apr 2022 - 29 Apr 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 140.00 |
Medpace Holdings (NASDAQ:MEDP) has had a rough month with its share price down 11%. However, stock prices are usually...
Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.
Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.